Home/Filings/4/0001209191-22-062389
4//SEC Filing

SIEGEL RICHARD W 4

Accession 0001209191-22-062389

CIK 0000883107other

Filed

Dec 21, 7:00 PM ET

Accepted

Dec 22, 11:20 AM ET

Size

29.8 KB

Accession

0001209191-22-062389

Insider Transaction Report

Form 4
Period: 2022-12-20
Transactions
  • Exercise/Conversion

    Common Stock (right to purchase)

    2022-11-15$0.41/sh10,000$4,1500 total
    Exercise: $0.41From: 2014-02-14Exp: 2023-02-14Common Stock (10,000 underlying)
  • Award

    Common Stock (right to purchase)

    2022-12-20$1.17/sh+15,000$17,47515,000 total
    Exercise: $1.17From: 2023-12-20Exp: 2029-12-20Common Stock (15,000 underlying)
Holdings
  • Common Stock (right to purchase)

    Exercise: $0.44From: 2016-02-18Exp: 2025-02-18Common Stock (9,000 underlying)
    9,000
  • Common Stock (right to purchase)

    Exercise: $0.68From: 2018-02-21Exp: 2027-02-21Common Stock (10,000 underlying)
    10,000
  • Common Stock

    409,838
  • Common Stock (right to purchase)

    Exercise: $0.42From: 2017-02-23Exp: 2026-02-23Common Stock (8,100 underlying)
    8,100
  • Common Stock (right to purchase)

    Exercise: $0.99From: 2016-11-17Exp: 2026-11-17Common Stock (2,000 underlying)
    2,000
  • Deferred Common Stock

    Common Stock (20,030 underlying)
    20,030
  • Common Stock (right to purchase)

    Exercise: $1.18From: 2016-11-17Exp: 2026-11-17Common Stock (2,000 underlying)
    2,000
  • Common Stock (right to purchase)

    Exercise: $1.85From: 2016-11-17Exp: 2026-11-17Common Stock (2,000 underlying)
    2,000
  • Common Stock (right to purchase)

    Exercise: $0.82From: 2019-05-23Exp: 2028-05-23Common Stock (10,000 underlying)
    10,000
  • Common Stock (right to purchase)

    Exercise: $0.52From: 2015-02-13Exp: 2024-02-13Common Stock (10,000 underlying)
    10,000
  • Common Stock (right to purchase)

    Exercise: $0.90From: 2016-11-17Exp: 2026-11-17Common Stock (2,000 underlying)
    2,000
  • Common Stock (right to purchase)

    Exercise: $0.84From: 2016-11-17Exp: 2026-11-17Common Stock (2,000 underlying)
    2,000
  • Common Stock (right to purchase)

    Exercise: $1.10From: 2016-11-17Exp: 2026-11-17Common Stock (2,000 underlying)
    2,000
  • Common Stock (right to purchase)

    Exercise: $1.05From: 2016-11-17Exp: 2026-11-17Common Stock (2,000 underlying)
    2,000
  • Common Stock (right to purchase)

    Exercise: $0.51From: 2020-05-22Exp: 2029-05-22Common Stock (10,000 underlying)
    10,000
  • Common Stock (right to purchase)

    Exercise: $0.45From: 2021-06-18Exp: 2027-06-18Common Stock (15,000 underlying)
    15,000
  • Common Stock (right to purchase)

    Exercise: $4.17From: 2022-12-28Exp: 2028-12-28Common Stock (15,000 underlying)
    15,000
Footnotes (6)
  • [F1]Each share of deferred common stock represents a right to receive one share of common stock.
  • [F2]The deferred common stock becomes payable upon the reporting person's termination of service as a director of the Company.
  • [F3]Pursuant to such plan, the reporting person elected to defer receipt of such shares and receive a cumulative total of 20,030 shares of deferred common stock which will all be accounted for under the Company's Non-Employee Director Deferred Compensation Plan.
  • [F4]Subject to certain rights and restrictions, beginning on this date, options vest in three equal annual installments.
  • [F5]Beginning on this date, subject to certain restrictions, the stock option vests in three equal annual installments.
  • [F6]The stock appreciation rights payable upon the reporting person's termination of service as a director of the Company were terminated, with stock options issued at identical exercise prices to the conversion prices of the respective stock appreciation rights. 2,000 were issued with an exercise price of $0.90, 2,000 were issued with an exercise price of $1.05, 2,000 were issued with an exercise price of $1.18, 2,000 were issued with an exercise price of $0.84, 2,000 were issued with an exercise price of $1.85, 2,000 were issued with an exercise price of $1.10, and 2,000 were issued with an exercise price of $0.99.

Issuer

NANOPHASE TECHNOLOGIES Corp

CIK 0000883107

Entity typeother

Related Parties

1
  • filerCIK 0001195154

Filing Metadata

Form type
4
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 11:20 AM ET
Size
29.8 KB